About ImmunoPDT
Our Mission
At Immuno PDT, our mission is to advance the field of biotechnology by developing innovative therapies that improve patient outcomes. We are dedicated to harnessing the power of science to create transformative solutions for unmet medical needs.
Immuno1 is a specialty pharmaceutical that harmlessly treats Prostate Cancer. It bridges gaps in the treatment and the unmet needs in Prostate Cancer conditions globally. Those who have Failed Treatment; those on Active Surveillance and those with difficult to treat prostate cancer disease. In time, the lack of harm done by the treatment and its long-term effectiveness may mean it competes with the current Primary treatments. There is also a significant upside in Bladder cancer and combined drug treatments.